)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Biostem Technologies
Biostem Technologies (BSEM) investor relations material
Biostem Technologies TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Strategic vision and platform development
Focused on building a differentiated regenerative medicine platform targeting advanced wound healing technologies and transformational outcomes in medicine.
Platform built on three pillars: differentiated technology, strong operational/clinical/scientific foundation, and scalable growth engine.
Expanded addressable market to six core segments, including orthopedics, chronic wound care, foot and ankle, urology, spine, and women's health, representing a $23B+ opportunity.
Recent acquisition of BioTissue and its Neox and Clarix product families diversified the portfolio and extended reach into surgical settings.
Transitioned from a single-product to a platform company, emphasizing resilience and growth.
Technology, clinical evidence, and product pipeline
Core technologies include BioRetain (proprietary dehydration of placental tissue), CryoTek (cryopreserved wet tissue), and SteriTek (room temperature wet tissue).
Over 90 clinical publications support the portfolio, with recent DFU study showing 53% healing vs. 31% for standard care; VLU study results forthcoming.
Ambulatory study on severe chronic wounds showed 66% closure at 26 weeks with an average of 1.6 applications.
Pipeline includes a particulated umbilical cord/placental product pending 510(k) clearance, with milestone payment tied to approval.
Focus on generating real-world and retrospective data to support reimbursement and clinical adoption.
Commercialization, reimbursement, and operational expansion
Expanded commercial team to 18 direct sales reps and 32 independent agents, leveraging GPO agreements with Premier, Vizient, and HPG.
Broadened reimbursement portfolio, reducing payer mix risk by combining Medicare and commercial payer coverage.
New CMS reimbursement methodology shifts from bundled rates to $127/sq cm plus application fee, enabling treatment of larger wounds and supporting hospital/ASC channels.
Facility in Pompano Beach, FL, with 100,000 sq cm monthly capacity, recently added clean room for tech transfer of BioTissue products.
Leadership strengthened with new Chief Commercial Officer and VP of Sales, both with prior BioTissue experience.
When will physician office sales stabilize?
Impact of 510(k) umbilical cord product?
Tech transfer of BioTissue products timeline
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Biostem Technologies earnings date
Q4 202513 Apr, 2026
Biostem Technologies
Next Biostem Technologies earnings date
Q4 202513 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
BioStem Technologies Inc. is a life sciences and regenerative medicine company that focuses on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care. The company uses its proprietary BioRetain process to produce perinatal tissue allografts, preserving key biological properties that support tissue regeneration. BioStem’s products are used in a range of medical applications, including wound management and tissue repair. The company's portfolio includes products such as VENDAJE, VENDAJE AC, and AmnioWrap2. The company is headquartered in Pompano Beach, Florida, and its shares are listed on the OTC market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage